|Bid||6.1200 x 200|
|Ask||6.1500 x 300|
|Day's Range||6.0700 - 6.2200|
|52 Week Range||5.7000 - 14.5100|
|PE Ratio (TTM)||-3.12|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Cancer immunotherapy developer Advaxis Inc said on Thursday Daniel O'Connor stepped down from his position as the company's chief executive and its board. Anthony Lombardo will immediately assume the role ...
Advaxis shares are down more than 25% over the past five sessions on no substantial news. Is the decline set to continue?
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Advaxis, Inc. Here are 5 ETFs with the largest exposure to ADXS-US. Comparing the performance and risk of Advaxis, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)